A lifetime of prevention the case of heart failure

Circulation

Volumn 106, Issue 24, 2002, Pages 2997-2998

  Yusuf, Salim ^a,c   Pitt, Bertram ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Editorials; Heart failure; Prevention; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; DEFIBRILLATOR; DIASTOLIC BLOOD PRESSURE; EDITORIAL; EXERCISE; HEALTH CARE PLANNING; HEALTH PROMOTION; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE; MORBIDITY; MORTALITY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADULT; AGE FACTORS; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PRIMARY PREVENTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEX FACTORS;

EID: 0037058850     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000046804.13847.5D     Document Type: Editorial

References (12)

1. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: The Framingham Heart Study. Circulation. 2002; 106:3068-3072.
2. Yusuf S. Two decades of progress in preventing vascular disease. Lancet. 2002;360:2-3.
3. Furberg CD, Psaty BM. Blood pressure and cardiovascular disease. In: Yusuf S, Cairns JA, Camm AJ, et al, eds. Evidence-Based Cardiology. 2nd Ed. London, UK: BMJ Books; 2002. In press.
4. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. New Engl J Med. 2002;347:305-313.
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med. 1991;325:293-302.
6. Anderson B. Swedberg K. Management of overt heart failure. In: Yusuf S, Cairns JA, Camm AJ, et al, eds. Evidence-Based Cardiology. 2nd Ed. London, UK: BMJ Books; 2002. In press.
7. Flather MD, Yusuf S, Køber L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. Lancet. 2000;355:1575-1581.
8. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA. 2000;283:1295-1302.
9. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl J Med. 1999;341:709-717.
10. Jong P, Yusuf S, Rousseau MF, et al. Enalapril Improves Survival and Life Expectancy in Patients With Reduced Left Ventricular Ejection Fractions. Available at: http://www.escardio.org/congress/berlin02/hotlines/Wednesday/XSOLVD. final.pdf. Accessed November 1, 2002.
11. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071-2078.
12. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. New Engl J Med. 2001; 345:1435-1443.